However, at present, it is uncertain if the PNPLA3 rs738409 C > G or TM6SF2 rs58542926 C > T genetic variants might also modulate the association between NAFLD and the risk of new-onset HF [9•]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.